Genvoya packs four HIV medicines into one once-daily tablet. That sounds wonderfully simpleand in many ways, it is. However, “one pill a day” still comes with important details involving food, timing, antacids, kidney function, dialysis, pregnancy, and drug interactions. In other words, the tablet may be compact, but its instruction manual deserves more than a casual glance.
This guide explains the standard Genvoya dosage, its strength, how to build a reliable dosing schedule, what to do after a missed dose, and which precautions deserve a conversation with your healthcare provider. It is educational information, not a replacement for individualized medical advice.
What Is Genvoya?
Genvoya is a prescription, fixed-dose combination medication used as a complete regimen for treating HIV-1 infection. It is approved for eligible adults and children who weigh at least 55 pounds, or 25 kilograms.
The medication may be prescribed to someone who has not previously taken antiretroviral therapy. It may also replace an existing HIV regimen in certain people whose viral load has remained suppressed, who have no history of treatment failure, and who do not have known resistance to Genvoya’s individual ingredients.
The four medicines inside one tablet
Each Genvoya tablet contains:
- Elvitegravir, 150 milligrams: an integrase strand transfer inhibitor that interferes with an enzyme HIV needs to copy itself.
- Cobicistat, 150 milligrams: a pharmacokinetic enhancer, commonly called a booster, that helps elvitegravir remain at an effective level in the body.
- Emtricitabine, 200 milligrams: a nucleoside reverse transcriptase inhibitor.
- Tenofovir alafenamide, 10 milligrams: another reverse transcriptase inhibitor that is converted into its active form inside cells.
Genvoya is available in one tablet strength in the United States. The tablet is green, capsule-shaped, film-coated, and marked with “GSI” on one side and “510” on the other.
The individual milligram amounts should not be compared directly with those in another HIV product. For example, different tenofovir formulations may use different doses because they are processed differently by the body. Medication math is not a build-your-own-burrito situation: do not substitute separate ingredients or another combination tablet unless your HIV specialist specifically changes the regimen.
What Is the Standard Genvoya Dosage?
The recommended Genvoya dosage for eligible adults and children weighing at least 25 kilograms is:
One tablet taken by mouth once daily with food.
The tablet already contains the complete daily amounts of its four active ingredients. Patients should not take two tablets to create a “stronger” dose, divide the dose between morning and evening, or add other HIV medicines unless a qualified healthcare provider has prescribed a specific combination.
Dosage for adults
Most eligible adults take one Genvoya tablet once a day with food. The dose generally does not change according to age, body size, viral load, or the time of day selected. The important requirements are taking it consistently, taking it with food, and confirming that kidney function and accompanying medications are compatible with the regimen.
Dosage for children
Children who weigh at least 55 pounds, or 25 kilograms, receive the same fixed tablet strength and once-daily schedule as adults. Genvoya has not been established as safe and effective under the U.S. indication for children who weigh less than 25 kilograms.
Because the dose is supplied as a fixed combination, it cannot be adjusted ingredient by ingredient for a smaller child. A pediatric HIV specialist can select an age- and weight-appropriate alternative when Genvoya is not suitable.
How to Take Genvoya Correctly
Always take Genvoya with food
Genvoya should be taken with food because food supports appropriate absorption of elvitegravir. The prescribing information does not require a particular cuisine, calorie count, or gourmet production. A normal meal or suitable snack may be used according to instructions from the patient’s healthcare team.
Someone who takes Genvoya with breakfast might pair it with eggs and toast, oatmeal and yogurt, or another dependable morning meal. An evening schedule could be anchored to dinner. The most useful meal is often the one that happens consistently rather than the one that looks impressive on social media.
Take it at approximately the same time every day
A consistent time helps maintain steady medication exposure and makes missed doses less likely. There is no universal requirement to take Genvoya in the morning or at night. The best schedule is the one that fits the patient’s daily routine and food intake.
Helpful adherence tools include a recurring phone alarm, a medication reminder application, a weekly checklist, or linking the tablet to an established meal. The tablets should remain in their original, tightly closed container and be stored below 86°F, or 30°C.
Swallowing difficulties require professional advice
Patients who have difficulty swallowing the tablet should ask a pharmacist or HIV clinician for advice before crushing, splitting, chewing, or dissolving it. The U.S. prescribing information does not provide routine instructions for altering the tablet, and changing its form without guidance could affect how the medication is delivered.
Genvoya and Antacids, Minerals, or Multivitamins
Products containing polyvalent minerals can bind with elvitegravir in the digestive tract and reduce its absorption. Genvoya should generally be separated by at least two hours from antacids, supplements, laxatives, buffered medicines, or multivitamins containing ingredients such as:
- Aluminum
- Magnesium
- Calcium
- Iron
- Zinc
For example, a person taking Genvoya with dinner at 7 p.m. might take a calcium-containing antacid before 5 p.m. or after 9 p.m., provided that plan agrees with professional instructions.
Do not assume that an over-the-counter product is harmless simply because it lives next to the toothpaste instead of behind the pharmacy counter. Show the pharmacist the complete ingredient label, especially when using heartburn treatments, mineral supplements, or multivitamins.
What Should You Do If You Miss a Dose?
If a Genvoya dose is missed, take it with food as soon as it is remembered. If it is almost time for the next scheduled dose, skip the missed tablet and return to the regular schedule.
Do not take two doses at the same time to make up for a missed dose.
Because “almost time” can depend on the person’s usual schedule and clinical circumstances, a pharmacist or prescriber can give more specific instructions. Patients who repeatedly miss doses should discuss the pattern openly with their HIV care team. The goal is to repair the routine, not to conduct a courtroom drama about who forgot the Tuesday tablet.
Missing or stopping antiretroviral treatment can allow the viral load to rise. It may also contribute to drug resistance, making HIV harder to treat. Refill requests should therefore be made before the bottle is empty, particularly before travel, holidays, insurance changes, or pharmacy closures.
What Happens If You Take Too Much Genvoya?
A patient who takes more Genvoya than prescribed should contact a healthcare professional, Poison Control, or an emergency department promptly. Do not wait for symptoms to appear and do not attempt to “balance” an extra tablet by independently skipping future doses.
Bring the medication container or an accurate list of medicines when seeking emergency care. This helps clinicians determine what was taken, how much was taken, and whether interactions with other substances require monitoring.
Does Kidney Function Change the Genvoya Dosage?
Genvoya’s fixed-dose tablet is not reduced to half a tablet or taken every other day for kidney impairment. Instead, clinicians determine whether the complete product is appropriate.
It may be used at the standard once-daily dose in adults and children weighing at least 25 kilograms whose estimated creatinine clearance is at least 30 milliliters per minute.
Genvoya is not recommended for patients with an estimated creatinine clearance from 15 to less than 30 milliliters per minute. It is also not recommended for people with clearance below 15 milliliters per minute who are not receiving chronic hemodialysis.
Dosage for adults receiving hemodialysis
Certain adults with end-stage renal disease who receive chronic hemodialysis may take one tablet daily with food. On dialysis days, the dose should be taken after the dialysis session has been completed.
This recommendation applies to qualifying adults under medical supervision. It should not be extended automatically to children receiving dialysis or to someone who has advanced kidney disease but is not on chronic hemodialysis.
Kidney monitoring
Before starting Genvoya and periodically during treatment, clinicians may check serum creatinine, estimated creatinine clearance, urine protein, and urine glucose. Serum phosphorus may also be checked in people with chronic kidney disease.
Cobicistat can produce a small increase in serum creatinine by affecting its secretion through the kidney tubules without necessarily reducing actual glomerular filtration. Even so, laboratory changes must be evaluated rather than dismissed. A confirmed creatinine increase greater than 0.4 milligrams per deciliter from baseline calls for closer renal monitoring.
Liver Impairment, Hepatitis B, and Pregnancy
Liver impairment
No dose adjustment is generally required for mild or moderate liver impairment, but Genvoya is not recommended in severe hepatic impairment, classified as Child-Pugh Class C. A liver specialist or HIV clinician should assess the complete medical history before treatment.
Hepatitis B testing
Patients should be tested for hepatitis B virus before or when Genvoya is started. Emtricitabine and tenofovir alafenamide have activity against hepatitis B, but Genvoya is not approved as a stand-alone hepatitis B treatment.
Stopping Genvoya in someone who has both HIV and hepatitis B can trigger a serious hepatitis B flare. Liver function may need to be monitored for several months after discontinuation, and separate hepatitis B treatment may be required. Never stop the medication merely because the viral load is undetectable or because the bottle has become inconveniently empty.
Pregnancy
Genvoya should not be initiated during pregnancy and is not recommended during pregnancy because elvitegravir and cobicistat exposure can become substantially lower during the second and third trimesters. Someone who becomes pregnant while taking Genvoya should contact the prescribing clinician promptly to discuss an alternative HIV regimen. Treatment should not be stopped independently while waiting for an appointment.
Important Genvoya Drug Interactions
Cobicistat strongly affects the CYP3A enzyme system, so Genvoya can raise the concentrations of certain medicines. Other drugs can lower Genvoya concentrations and potentially reduce viral control. This makes a complete medication review essential before treatment and whenever a new prescription, supplement, or recreational substance is considered.
Examples of medicines or products that may be contraindicated with Genvoya include:
- Rifampin
- Carbamazepine, phenytoin, and phenobarbital
- St. John’s wort
- Simvastatin and lovastatin
- Oral midazolam and triazolam
- Lurasidone and pimozide
- Alfuzosin
Many additional medicines require avoidance, dosage changes, or extra monitoring. These can include certain cholesterol drugs, sedatives, corticosteroids, heart medicines, erectile dysfunction treatments, seizure medicines, and hepatitis C therapies. The list above is not complete.
Patients should keep an updated list of prescription drugs, over-the-counter remedies, vitamins, herbal products, and supplements. Share it with every prescriber and pharmacist. Genvoya should generally not be combined with another medicine containing elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide, or tenofovir disoproxil fumarate.
Side Effects That May Affect the Dosing Routine
Nausea is the most commonly reported Genvoya side effect. Diarrhea, headache, and fatigue have also occurred in clinical studies. Mild nausea may improve as the body adjusts, and taking the tablet with a dependable meal may make the routine more comfortable.
Do not skip doses automatically because of nausea or another suspected side effect. Contact the healthcare team for strategies and an assessment. Severe or persistent symptoms may require testing or a regimen change rather than improvised dose reductions.
Seek prompt medical attention for symptoms suggesting a severe allergic reaction, serious kidney problem, liver injury, or lactic acidosis. Warning signs can include facial or throat swelling, difficulty breathing, markedly reduced urination, yellow skin or eyes, dark urine, unusual weakness, rapid breathing, severe abdominal symptoms, or an abnormal heartbeat.
Practical Experiences: Making a Once-Daily Schedule Work
The following examples are realistic, educational scenarios rather than testimonials from identified patients. They illustrate how small planning decisions can make Genvoya dosing easier in daily life.
Experience 1: Building the dose into breakfast
A person with a predictable office schedule chooses breakfast as the dosing anchor. The bottle stays in a secure kitchen cabinet near the breakfast supplies, not on the dining table where children or visitors could reach it. A recurring 7:30 a.m. phone reminder appears every day, including weekends.
The strategy works because it combines three cues: food, location, and an electronic reminder. On mornings when there is no time for a full breakfast, the person keeps suitable grab-and-go food available. The important lesson is not that morning dosing is superior; it is that the routine has a backup plan.
Experience 2: Working rotating shifts
A night-shift employee initially tries to take Genvoya at “dinner,” but dinner moves from 6 p.m. to midnight to 9 a.m. depending on the workweek. After discussing the problem with the clinic, the employee chooses a stable clock time and keeps a planned meal or snack available at that time.
This approach reduces confusion caused by naming meals. For shift workers, “breakfast” may occur while everyone else is thinking about pizza. A clock-based schedule can be easier, provided the dose is still taken with food and any change in timing is reviewed professionally.
Experience 3: Separating a multivitamin
Another patient takes Genvoya with breakfast and a multivitamin containing calcium, iron, magnesium, and zinc. A pharmacist notices the overlap during a medication review. The patient moves the multivitamin to lunchtime, creating more than two hours of separation.
The experience highlights why supplement labels matter. “Natural,” “daily,” and “wellness” are marketing words, not interaction guarantees. Bringing the actual bottlesor clear photographs of their labelsto an appointment can prevent guesswork.
Experience 4: Avoiding the empty-bottle emergency
A traveler once realizes on Friday evening that only two tablets remain and the specialty pharmacy will not reopen until Monday. After resolving the refill with the care team, the person adopts a new rule: request medication when at least seven to ten days remain.
Before future trips, the patient checks the supply, pharmacy delivery schedule, insurance limits, time-zone plan, and food access. Genvoya goes in carry-on luggage in its original labeled container rather than in checked baggage, which occasionally decides to take a vacation of its own.
Experience 5: Responding to a missed dose calmly
A patient remembers the tablet several hours late and feels tempted to take two doses the next morning “to catch up.” Instead, the patient checks the written missed-dose instructions and contacts the pharmacist because the next dose is approaching.
The bigger improvement comes afterward: the dosing alarm is changed from a silent notification to an audible reminder, and a trusted household member becomes an optional backup. A missed dose becomes a reason to strengthen the system, not to double the medication or abandon the regimen.
Experience 6: Understanding a laboratory change
After starting Genvoya, a patient sees a small rise in serum creatinine and assumes the kidneys are failing. The HIV clinician explains that cobicistat can affect creatinine secretion, reviews the size and timing of the change, and evaluates the full kidney panel rather than one number in isolation.
The practical lesson is to attend laboratory appointments and ask what the trend means. Online portals deliver results quickly, but they do not always deliver context. Neither panic nor dismissal is appropriate when kidney values change.
Frequently Asked Questions About Genvoya Dosage
Can Genvoya be taken at night?
Yes. It may generally be taken in the morning or evening, as long as it is taken once daily with food at a consistent time. Choose a schedule with the prescribing clinician that fits meals, work, and interacting medicines.
Can the Genvoya dose be reduced if side effects occur?
No self-directed reduction is recommended. Because the tablet contains four medicines in fixed amounts, taking part of a tablet may provide unreliable doses. The clinician can evaluate the symptoms and prescribe another complete regimen when necessary.
Is Genvoya used for HIV prevention?
Genvoya is approved as HIV treatment, not as pre-exposure prophylaxis or post-exposure prophylaxis. People seeking HIV prevention should obtain a regimen specifically recommended for that purpose.
How long is Genvoya treatment continued?
HIV treatment is typically long term. Continue taking Genvoya for as long as it remains prescribed, even when the viral load is undetectable and the patient feels well. An undetectable result means the treatment is working; it does not mean the medication has become decorative.
Conclusion
The standard Genvoya dosage is one tablet once daily with food for eligible adults and children weighing at least 25 kilograms. Each tablet contains 150 milligrams of elvitegravir, 150 milligrams of cobicistat, 200 milligrams of emtricitabine, and 10 milligrams of tenofovir alafenamide.
Consistency is essential. Take the tablet at approximately the same time each day, separate it from mineral-containing antacids and supplements as directed, and never double a missed dose. Kidney function, liver health, pregnancy, dialysis, hepatitis B status, and other medications can change whether Genvoya is appropriateeven though the physical tablet and standard dose remain the same.
Note: This article provides general education and does not establish an individual treatment plan. Patients should follow the instructions supplied by their HIV specialist and pharmacist and should not start, stop, crush, split, or change Genvoya without professional guidance.
